National Cancer Institute; Notice of Closed Meetings, 12111-12112 [2016-05019]
Download as PDF
12111
Federal Register / Vol. 81, No. 45 / Tuesday, March 8, 2016 / Notices
Dated: March 2, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–05020 Filed 3–7–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Survey To Assess the
Feasibility of Establishing a
Gynecologic Specimen Bank (NCI)
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute, the National
Institutes of Health (NIH) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited to address one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
SUMMARY:
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
The quality, utility, and clarity of the
information to be collected; and (4)
Minimize the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
gynecologic specimen bank (NCI), 0925–
NEW, National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information
Collection: The National Cancer
Institute is assessing the feasibility of
developing a tissue bank that would
include tube and ovary tissues from
women undergoing surgery for benign
conditions, risk reduction and early
stage cancer. Collecting tissues from
tubes and ovaries containing clinically
unsuspected precursors or early stage
cancer is challenging, especially among
women that are not at increased genetic
risk. However, given that many
pathology laboratories have enhanced
their processing protocols for
gynecologic surgical specimens
removed for benign indications, it may
be possible to develop a tissue resource.
Accordingly, we are requesting
information via a survey about the
volume of samples that are accessioned
at different pathology laboratories, and
the methods used to process these
samples. These data would provide
information necessary to assess the
feasibility of establishing a tissue bank
for research and provide insights into
the best design of a pilot study.
OMB approval is requested for 1 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 42 hours.
TO SUBMIT COMMENTS AND FOR FURTHER
INFORMATION: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Goli Samimi, Program
Director, Breast and Gynecologic Cancer
Research Group, Division of Cancer
Prevention, 9609 Medical Center Drive,
MSC 9783, Bethesda, MD 20892, or call
non-toll-free number (240) 276–6582, or
Email your request, including your
address to: goli.samimi@nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: Survey to assess
the feasibility of establishing a
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Frequency of
response per
respondent
Time per
response (in
hours)
Category of respondent
Form name
Lab Managers .......................................................
Survey. ..........................
250
1
10/60
42
Totals .............................................................
.......................................
250
........................
........................
42
Dated: March 2, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, NIH.
Health, 31 Center Drive, Building 31,
Conference Room 10, Bethesda, MD,
20892 which was published in the
Federal Register on February 26, 2016,
81 FR 9867.
The meeting notice is amended to
change the meeting date to March 29,
2016. The meeting is open to the public.
[FR Doc. 2016–05021 Filed 3–7–16; 8:45 am]
BILLING CODE 4140–01–P
asabaliauskas on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: March 2, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
[FR Doc. 2016–05018 Filed 3–7–16; 8:45 am]
BILLING CODE 4140–01–P
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Board of Scientific Advisors,
March 29, 2016, 08:30 a.m. to March 30,
2016, 12:00 p.m., National Institutes of
VerDate Sep<11>2014
17:02 Mar 07, 2016
Jkt 238001
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Burden hours
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\08MRN1.SGM
08MRN1
12112
Federal Register / Vol. 81, No. 45 / Tuesday, March 8, 2016 / Notices
asabaliauskas on DSK3SPTVN1PROD with NOTICES
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Omnibus R03 & R21 SEP–13.
Date: April 6–7, 2016.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, 7W114, Bethesda, MD 20892–8329,
240–276–6371, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Omnibus R03 & R21 SEP–5.
Date: April 14–15, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Bethesda, MD 20878.
Contact Person: Thomas A. Winters, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, 7W412, Bethesda, MD 20892–
9750, 240–276–6386, twinters@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis, Panel NCI
Omnibus R03 & R21 SEP–17.
Date: April 14, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2W030, Rockville, MD 20890, (Telephone
Conference Call).
Contact Person: Gerard Lacourciere, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W248, Bethesda, MD 20892–
9750, 240–276–5457, gerald.lacourciere@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Omnibus SEP–18.
Date: April 14, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W104, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Eun Ah Cho, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W104, Bethesda, MD
20892–9750, 240–276–6342, choe@
mail.nih.gov.
VerDate Sep<11>2014
17:02 Mar 07, 2016
Jkt 238001
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Omnibus SEP–19.
Date: April 15, 2016.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W030, Rockville, MD 20890, (Telephone
Conference Call).
Contact Person: Clifford W. Schweinfest,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, 7W108,
Bethesda, MD 20892–9750, 240–276–6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Collaborative Research in Integrative Cancer
Biology.
Date: April 19, 2016.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
4W030, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Gerard Lacourciere, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W248, Rockville, MD 20850,
240–276–5458, gerard.lacourciere@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 2, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–05019 Filed 3–7–16; 8:45 am]
BILLING CODE 4140–01–P
ADVISORY COUNCIL ON HISTORIC
PRESERVATION
Notice of Advisory Council on Historic
Preservation Quarterly Business
Meeting
Advisory Council on Historic
Preservation.
ACTION: Notice of Advisory Council on
Historic Preservation Quarterly Business
Meeting.
AGENCY:
Notice is hereby given that
the Advisory Council on Historic
Preservation (ACHP) will hold its next
quarterly meeting on Thursday, March
24, 2016. The meeting will be held at
SUMMARY:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
the Westin Tampa Harbour Island Hotel
at 725 South Harbour Island Boulevard,
Tampa, Florida, starting at 10:30 a.m.
DATES: The quarterly meeting will take
place on Thursday, March 24, 2016,
starting at 10:30 a.m.
ADDRESSES: The meeting will be held
the Westin Tampa Harbour Island Hotel
at 725 South Harbour Island Boulevard,
Tampa, Florida.
FOR FURTHER INFORMATION CONTACT:
Cindy Bienvenue, 202–517–0202,
cbienvenue@achp.gov.
SUPPLEMENTARY INFORMATION: The
Advisory Council on Historic
Preservation (ACHP) is an independent
federal agency that promotes the
preservation, enhancement, and
sustainable use of our nation’s diverse
historic resources, and advises the
President and the Congress on national
historic preservation policy. The goal of
the National Historic Preservation Act
(NHPA), which established the ACHP in
1966, is to have federal agencies act as
responsible stewards of our nation’s
resources when their actions affect
historic properties. The ACHP is the
only entity with the legal responsibility
to encourage federal agencies to factor
historic preservation into federal project
requirements. For more information on
the ACHP, please visit our Web site at
www.achp.gov.
The agenda for the upcoming
quarterly meeting of the ACHP is the
following:
I. Chairman’s Welcome
II. Historic Preservation Policy and
Programs
A. Building a More Inclusive
Preservation Program
1. American Latino Heritage Initiative
2. ACHP Youth Initiatives
B. Preservation50 and the ACHP
Public Policy Initiative
C. Policy Statement for Resilient
Communities
D. White House Council on Climate
Preparedness and Resilience
E. Historic Preservation Legislation in
the 114th Congress
1. Historic Preservation Fund
Reauthorization
2. Historically Black Colleges and
Universities Reauthorization
3. African American Civil Rights
Network legislation
4. Preservation Research at
Institutions Serving Minorities
(PRISM) Act
5. Native American Tourism and
Improving Visitor Experience
(NATIVE) Act
III. Section 106 Issues
A. Federal Agency Support for SHPOs
and THPOs
B. Public Involvement in the Section
E:\FR\FM\08MRN1.SGM
08MRN1
Agencies
[Federal Register Volume 81, Number 45 (Tuesday, March 8, 2016)]
[Notices]
[Pages 12111-12112]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05019]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material,
[[Page 12112]]
and personal information concerning individuals associated with the
grant applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, NCI Omnibus R03 & R21 SEP-13.
Date: April 6-7, 2016.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, 7W114, Bethesda, MD 20892-8329, 240-276-6371,
decluej@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, NCI Omnibus R03 & R21 SEP-5.
Date: April 14-15, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Bethesda, MD 20878.
Contact Person: Thomas A. Winters, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, 7W412,
Bethesda, MD 20892-9750, 240-276-6386, twinters@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis,
Panel NCI Omnibus R03 & R21 SEP-17.
Date: April 14, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 2W030, Rockville, MD 20890, (Telephone Conference
Call).
Contact Person: Gerard Lacourciere, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W248, Bethesda, MD 20892-9750, 240-276-5457,
gerald.lacourciere@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, NCI Omnibus SEP-18.
Date: April 14, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W104, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Eun Ah Cho, Ph.D., Scientific Review Officer,
Special Review Branch, Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W104,
Bethesda, MD 20892-9750, 240-276-6342, choe@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, NCI Omnibus SEP-19.
Date: April 15, 2016.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W030, Rockville, MD 20890, (Telephone Conference
Call).
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific
Review Officer, Special Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, 7W108, Bethesda, MD 20892-9750, 240-276-6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Collaborative Research in Integrative Cancer Biology.
Date: April 19, 2016.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 4W030, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Gerard Lacourciere, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W248, Rockville, MD 20850, 240-276-5458,
gerard.lacourciere@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: March 2, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-05019 Filed 3-7-16; 8:45 am]
BILLING CODE 4140-01-P